Understanding Retinal Conditions and Your Vision
Understanding the Retina and How It Works
Think of your eye as a camera. Light enters through the cornea (the clear front surface) and passes through the pupil. The lens then focuses this light onto the retina at the back of the eye, much like film in a camera. The retina captures the image and converts it into electrical impulses.
The macula is the small, central area of the retina responsible for sharp, detailed vision. You use your macula when you read, drive, recognize faces, and see fine details. Damage to the macula can make these everyday tasks difficult, even if your side vision remains intact.
Once the retina converts light into electrical signals, these impulses travel along the optic nerve to the brain. The brain interprets these signals as the images you see. Any disruption along this pathway can affect your vision.
Several layers work together to keep the retina healthy. The retinal pigment epithelium (RPE) nourishes retinal cells. The Bruch membrane provides structural support. The choroid, a layer of blood vessels, supplies oxygen. Disease can affect any of these structures.
Common Retinal Conditions
Age-related macular degeneration (AMD) is one of the most common retinal conditions. In 2019, an estimated 19.8 million Americans aged 40 and older were living with AMD (CDC, 2019).
AMD comes in two distinct forms that require different treatments. Dry AMD is more common and involves gradual thinning of the macula. It can progress to geographic atrophy, where patches of retinal cells are lost. Wet AMD is less common but more severe. It occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood.
Diabetic retinopathy (DR) and diabetic macular edema (DME) are caused by damage to the small blood vessels in the retina from high blood sugar. The prevalence of diabetes-related eye disease reached 20.8% in 2021 (AAO, 2025). However, rates of the most severe forms have improved over the past 20 years thanks to better treatments and screening (AAO, 2025).
A retinal vein occlusion (RVO) occurs when a vein carrying blood away from the retina becomes blocked. This can cause swelling in the macula and vision loss. Risk factors include high blood pressure, diabetes, and glaucoma.
A retinal detachment happens when the retina pulls away from the supportive tissue beneath it. Without prompt treatment, retinal detachment can lead to severe, lasting vision loss. It occurs most often in people with high myopia (severe nearsightedness), those who have had previous eye surgery, or those with a family history.
Inherited retinal diseases (IRDs) are a group of genetic conditions that cause progressive vision loss. The most common IRD is retinitis pigmentosa, which affects roughly 1 in 4,500 people. Overall, inherited retinal diseases affect about 1 in 3,450 individuals (PubMed, 2023).
Who Is Affected and Risk Factors
Age is the strongest risk factor for many retinal conditions, particularly AMD. The prevalence of AMD rises from about 2% among people aged 40 to 44 to 46.6% among those aged 85 and older (CDC, 2019).
Diabetes mellitus is the primary risk factor for diabetic retinopathy and DME. High blood sugar damages the tiny blood vessels in the retina over time. Hypertension and cardiovascular disease also increase the risk of retinal vein occlusions.
Cigarette smoking is a well-established risk factor for AMD. Smoking accelerates damage to the retina. Quitting smoking at any age can help reduce this risk. A healthy diet rich in leafy greens and fish may also support retinal health.
A family history of retinal disease increases your risk. AMD, inherited retinal diseases, and retinal detachment all have genetic components. If a close relative has been diagnosed with a retinal condition, informing your eye care provider is important.
Retinal diseases affect people of all backgrounds. AMD rates are lower for non-Hispanic Black individuals (7.0%) compared with other racial and ethnic groups (13.3%) (CDC, 2019). However, diabetic retinopathy disproportionately affects Hispanic and Black populations. High myopia is a significant risk factor for retinal detachment.
Signs and Symptoms
Many retinal conditions affect the macula first. You may notice blurred or distorted vision, especially when reading or looking at faces. Straight lines may appear wavy or bent.
Floaters are small spots, lines, or cobweb-like shapes that drift across your vision. Occasional floaters are common and usually harmless. However, a sudden increase in floaters, especially with flashes of light, can signal a retinal tear or detachment. See a retina specialist or go to the emergency room immediately if you experience these symptoms.
Some conditions, such as retinitis pigmentosa, cause gradual loss of peripheral (side) vision. You may notice difficulty seeing in dim lighting before your central vision is affected.
A sudden loss of vision in one eye, or a curtain or shadow across part of your visual field, is a medical emergency. See a retina specialist or go to the emergency room immediately.
Diagnosis and Testing
A dilated eye exam is the most important first step in detecting retinal disease. Drops widen the pupils, allowing a retina specialist to see the retina clearly. This exam can reveal signs of AMD, diabetic retinopathy, and retinal tears before you notice symptoms.
Optical coherence tomography (OCT) is a non-invasive imaging test that creates detailed cross-sectional pictures of the retina. It allows a retina specialist to measure retinal thickness and detect fluid or swelling.
Fluorescein angiography involves injecting a special dye into a vein in the arm. The retina is then photographed as the dye moves through its blood vessels. This test reveals areas of leaking or abnormal blood vessels.
For patients with suspected inherited retinal diseases, genetic testing can identify the specific gene mutation. Knowing the genetic cause can guide treatment decisions and may determine eligibility for gene therapy or clinical trials.
Treatment Options
Anti-VEGF therapy blocks vascular endothelial growth factor (VEGF), a protein that drives abnormal blood vessel growth and leakage. These medications are delivered as intravitreal injections (injections directly into the eye). Anti-VEGF agents are used for wet AMD, DME, retinal vein occlusion, and diabetic retinopathy.
Commonly used anti-VEGF medications include:
- Eylea (aflibercept): Typically given every 4 to 8 weeks after an initial loading phase.
- Eylea HD (high-dose aflibercept): Extended dosing intervals of 8 to 16 weeks after loading.
- Lucentis (ranibizumab): The first anti-VEGF approved for eye use. Given every 4 weeks.
- Avastin (bevacizumab): FDA-approved for cancer but used off-label for eye conditions. Typically given every 4 to 6 weeks.
- Vabysmo (faricimab): A bispecific antibody (anti-VEGF and anti-Ang-2). Given every 4 to 16 weeks depending on response.
- Beovu (brolucizumab): Given every 8 to 12 weeks. Carries a risk of retinal vasculitis (inflammation of the retinal blood vessels).
Geographic atrophy is an advanced form of dry AMD. It requires different treatment than wet AMD. Two complement inhibitors have been FDA-approved to slow its progression. Syfovre (pegcetacoplan), a C3 complement inhibitor, is given monthly or every other month. Izervay (avacincaptad pegol), a C5 complement inhibitor, is given monthly. These treatments do not restore lost vision but can slow retinal cell loss. These complement inhibitor treatments are specifically for geographic atrophy associated with dry AMD and are different from wet AMD treatments.
Laser photocoagulation uses focused beams of light to seal leaking blood vessels or treat abnormal tissue in the retina. It is used for diabetic retinopathy, retinal tears, and certain retinal vein occlusions. Laser therapy can help prevent further vision loss.
Vitrectomy (surgery to remove the gel inside the eye) treats retinal detachment, macular holes, and epiretinal membranes. A retina specialist makes tiny incisions and uses specialized instruments to repair the retina. Other surgical options include scleral buckling (placing a silicone band around the eye) and pneumatic retinopexy (injecting a gas bubble into the eye).
Luxturna (voretigene neparvovec) is the first FDA-approved gene therapy for an inherited retinal disease. It treats vision loss caused by mutations in the RPE65 gene. Clinical trials are ongoing for gene therapies targeting other inherited retinal diseases.
Corticosteroid implants reduce inflammation and swelling in the retina. Ozurdex (dexamethasone implant) releases medication over several months. Iluvien (fluocinolone acetonide implant) provides sustained release for up to three years. These are used for DME and retinal vein occlusion when anti-VEGF therapy alone is not sufficient.
What to Expect
Intravitreal injections are the most common retina procedure. Numbing drops or a small amount of anesthetic is applied to the eye first. The injection takes only a few seconds. You may feel pressure or mild discomfort. Most people return to normal activities the same day.
Retinal surgeries such as vitrectomy are usually performed on an outpatient basis. The procedure is done under local or general anesthesia. Recovery time varies by surgery type. Some patients need to maintain a specific head position for several days if a gas bubble is placed in the eye.
Many retinal conditions require long-term monitoring and repeated treatments. Regular follow-up visits with OCT imaging help a retina specialist track your response to treatment and adjust the plan as needed.
Living with a Retinal Condition
Vision changes from retinal conditions can affect reading, driving, cooking, and recognizing faces. Low vision aids, including magnifying devices and specialized lighting, can help. Many patients benefit from working with a low vision rehabilitation specialist.
Managing underlying health conditions such as diabetes and high blood pressure can slow disease progression. Wearing UV-protective sunglasses, eating a nutrient-rich diet, and not smoking all contribute to retinal health. The AREDS2 formula (a specific combination of vitamins and minerals) has been shown to reduce the risk of AMD progression in certain stages (NEI).
A diagnosis of a retinal condition can bring feelings of anxiety, frustration, or sadness. These feelings are normal. Support groups and organizations such as the Foundation Fighting Blindness or BrightFocus Foundation can provide resources for patients and families.
When to See a Retina Specialist
Certain symptoms require immediate attention. See a retina specialist or go to the emergency room immediately if you experience any of the following:
- A sudden increase in floaters
- Flashes of light in your vision
- A curtain or shadow across part of your visual field
- Sudden vision loss in one eye
Even without symptoms, regular dilated eye exams are important for detecting retinal disease early. Adults over 50 should have comprehensive eye exams as recommended by their eye care provider. People with diabetes should have a dilated retinal exam at least once a year.
A retina specialist is a board-certified ophthalmologist with additional fellowship training in vitreoretinal diseases. Your optometrist or general ophthalmologist can refer you if a retinal condition is suspected. Early referral can make a significant difference in outcomes.
Questions and Answers
An ophthalmologist is a medical doctor trained to diagnose and treat eye diseases. A retina specialist is an ophthalmologist who has completed one to two additional years of fellowship training focused on diseases and surgery of the retina and vitreous. Retina specialists handle complex conditions such as macular degeneration, diabetic retinopathy, and retinal detachment.
Yes. Many retinal conditions, including diabetic retinopathy and early AMD, can be present without noticeable symptoms. A dilated eye exam allows a retina specialist or ophthalmologist to see changes in the retina before vision loss occurs. This is why routine screening is so important for people with risk factors.
Intravitreal injections are among the most commonly performed procedures in medicine today. Serious complications such as infection are rare, occurring in fewer than 1 in 2,000 injections (ASRS). A retina specialist takes careful steps to minimize risk, including antiseptic preparation before each injection. Most patients tolerate the injections well and experience only brief, mild discomfort.
Outcomes depend on the type and severity of the retinal condition, how early treatment begins, and how the condition responds to therapy. Some patients experience meaningful improvement in vision. Others benefit by maintaining their current level of vision and preventing further decline. Early detection and consistent follow-up give the best chance of preserving vision.
Research in retinal medicine is advancing rapidly. Recent developments include biosimilar medications, sustained-release drug delivery systems that may reduce the frequency of injections, and gene therapies for inherited retinal diseases. Multiple clinical trials are underway. A retina specialist can discuss whether any emerging treatments may be appropriate for your condition.